Share Price and Basic Stock Data
Last Updated: December 18, 2025, 3:52 pm
| PEG Ratio | 0.63 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
NG Industries Ltd operates in the hospitals and medical services sector, a crucial area that has witnessed significant shifts in demand patterns, particularly post-pandemic. As of the latest reporting, the company’s stock price stood at ₹122, with a market capitalization of ₹40.9 Cr. Revenue trends show a mixed performance; for FY 2025, sales reported ₹16.55 Cr, slightly down from ₹18.70 Cr in FY 2023. This decline may raise eyebrows, especially given the sector’s growth potential. Quarterly results indicate fluctuating sales, with the most recent quarter (Mar 2025) recording ₹4.07 Cr, down from ₹4.38 Cr in the previous quarter. The variability in sales could be attributed to seasonal demand or operational challenges, warranting careful scrutiny from prospective investors.
Profitability and Efficiency Metrics
Profitability metrics for NG Industries present a nuanced picture. The company reported a net profit of ₹7.44 Cr, translating to an impressive return on equity (ROE) of 20.7%. However, the operating profit margin (OPM) of 8.92% appears modest when compared to industry norms, indicating potential room for improvement in cost management. Additionally, the interest coverage ratio (ICR) of 223.85x suggests that the company has a robust ability to meet its interest obligations, which is a positive sign for risk-averse investors. However, the declining OPM trend over recent quarters—from 12.01% in Sep 2023 to 8.92% in Mar 2025—could signal rising operational costs or inefficiencies that need addressing to sustain profitability.
Balance Sheet Strength and Financial Ratios
Examining the balance sheet, NG Industries appears to be in a strong position. With total borrowings recorded at ₹1.06 Cr against reserves of ₹35.81 Cr, the company exhibits a sound capital structure with a debt-to-equity ratio of just 0.04. This low leverage indicates minimal financial risk and a strong capacity to fund growth through internal resources. Furthermore, with a current ratio of 1.65, the company seems well-equipped to cover its short-term liabilities. However, the cash conversion cycle (CCC) of 73.29 days raises concerns; while it’s not excessively high, improving this metric could enhance liquidity and operational efficiency. Investors should monitor how the company manages its working capital in the coming quarters.
Shareholding Pattern and Investor Confidence
The shareholding pattern of NG Industries reveals a strong promoter presence, with promoters holding a steady 74.50% stake. This level of control typically suggests long-term commitment and confidence in the company’s direction, which could be reassuring for investors. The public shareholding, standing at 25.49%, has seen a gradual increase in the number of shareholders—from 1,650 in Dec 2022 to 2,250 by Sep 2025. This growth reflects rising investor interest, which can be a positive indicator of market sentiment. However, the absence of institutional investors (FIIs and DIIs) may be a red flag, as their involvement often lends credibility and stability to a stock. Retail investors might want to consider this aspect while evaluating their exposure to NG Industries.
Outlook, Risks, and Final Insight
Looking ahead, NG Industries faces both opportunities and challenges. The healthcare sector is poised for growth, driven by increasing healthcare awareness and demand for medical services. However, the company must navigate operational inefficiencies that have impacted profitability and sales trends. Risks include potential regulatory changes affecting the healthcare landscape and rising costs that could further squeeze margins. Investors should keep a close watch on quarterly performance to gauge whether the company can stabilize its revenue and improve its profitability metrics. While the fundamentals suggest a solid company, the challenges it faces may temper short-term investor enthusiasm. A balanced approach, weighing the strengths against the risks, will be essential for anyone considering an investment in NG Industries.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 41.6 Cr. | 124 | 194/120 | 8.48 | 117 | 2.82 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 21.5 Cr. | 20.5 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 8.57 Cr. | 8.29 | 20.8/7.86 | 95.2 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 113 Cr. | 60.4 | 98.7/55.2 | 25.0 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.0 Cr. | 3.71 | 7.29/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,128.93 Cr | 688.31 | 94.53 | 93.18 | 0.35% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.54 | 4.89 | 4.07 | 4.20 | 4.53 | 4.33 | 3.95 | 4.07 | 3.70 | 4.38 | 4.00 | 4.47 | 3.70 |
| Expenses | 4.74 | 4.69 | 3.59 | 3.87 | 4.00 | 3.81 | 3.55 | 3.56 | 3.31 | 3.93 | 3.59 | 3.92 | 3.37 |
| Operating Profit | 0.80 | 0.20 | 0.48 | 0.33 | 0.53 | 0.52 | 0.40 | 0.51 | 0.39 | 0.45 | 0.41 | 0.55 | 0.33 |
| OPM % | 14.44% | 4.09% | 11.79% | 7.86% | 11.70% | 12.01% | 10.13% | 12.53% | 10.54% | 10.27% | 10.25% | 12.30% | 8.92% |
| Other Income | 0.39 | 5.74 | 1.10 | 1.15 | 2.02 | 0.35 | 0.26 | 1.87 | 0.32 | 3.20 | 7.67 | -3.18 | 0.11 |
| Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 |
| Depreciation | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | 0.18 | 0.18 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.15 |
| Profit before tax | 1.05 | 5.81 | 1.45 | 1.35 | 2.42 | 0.69 | 0.48 | 2.25 | 0.57 | 3.49 | 7.91 | -2.82 | 0.27 |
| Tax % | 17.14% | 11.70% | 20.00% | 14.81% | 16.12% | 7.25% | 10.42% | 13.78% | 14.04% | 15.19% | 15.17% | -13.83% | 25.93% |
| Net Profit | 0.87 | 5.13 | 1.17 | 1.15 | 2.03 | 0.64 | 0.43 | 1.94 | 0.50 | 2.97 | 6.71 | -2.43 | 0.19 |
| EPS in Rs | 2.60 | 15.31 | 3.49 | 3.43 | 6.06 | 1.91 | 1.28 | 5.79 | 1.49 | 8.86 | 20.03 | -7.25 | 0.57 |
Last Updated: August 19, 2025, 1:20 pm
Below is a detailed analysis of the quarterly data for NG Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3.70 Cr.. The value appears to be declining and may need further review. It has decreased from 4.47 Cr. (Mar 2025) to 3.70 Cr., marking a decrease of 0.77 Cr..
- For Expenses, as of Jun 2025, the value is 3.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.92 Cr. (Mar 2025) to 3.37 Cr., marking a decrease of 0.55 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.33 Cr.. The value appears to be declining and may need further review. It has decreased from 0.55 Cr. (Mar 2025) to 0.33 Cr., marking a decrease of 0.22 Cr..
- For OPM %, as of Jun 2025, the value is 8.92%. The value appears to be declining and may need further review. It has decreased from 12.30% (Mar 2025) to 8.92%, marking a decrease of 3.38%.
- For Other Income, as of Jun 2025, the value is 0.11 Cr.. The value appears strong and on an upward trend. It has increased from -3.18 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 3.29 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.27 Cr.. The value appears strong and on an upward trend. It has increased from -2.82 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 3.09 Cr..
- For Tax %, as of Jun 2025, the value is 25.93%. The value appears to be increasing, which may not be favorable. It has increased from -13.83% (Mar 2025) to 25.93%, marking an increase of 39.76%.
- For Net Profit, as of Jun 2025, the value is 0.19 Cr.. The value appears strong and on an upward trend. It has increased from -2.43 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 2.62 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.57. The value appears strong and on an upward trend. It has increased from -7.25 (Mar 2025) to 0.57, marking an increase of 7.82.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.80 | 14.86 | 16.93 | 17.28 | 17.36 | 17.67 | 18.50 | 11.88 | 18.42 | 18.70 | 16.88 | 16.55 | 16.22 |
| Expenses | 11.06 | 12.20 | 13.80 | 14.40 | 14.30 | 14.85 | 15.71 | 10.62 | 16.06 | 16.81 | 14.87 | 14.76 | 14.61 |
| Operating Profit | 2.74 | 2.66 | 3.13 | 2.88 | 3.06 | 2.82 | 2.79 | 1.26 | 2.36 | 1.89 | 2.01 | 1.79 | 1.61 |
| OPM % | 19.86% | 17.90% | 18.49% | 16.67% | 17.63% | 15.96% | 15.08% | 10.61% | 12.81% | 10.11% | 11.91% | 10.82% | 9.93% |
| Other Income | 0.57 | 0.53 | -0.07 | -0.02 | -0.24 | -0.34 | -0.05 | 0.14 | 1.63 | 8.37 | 4.51 | 8.00 | 5.03 |
| Interest | 0.29 | 0.04 | 0.06 | 0.07 | 0.08 | 0.18 | 0.16 | 0.08 | 0.09 | 0.09 | 0.07 | 0.04 | 0.06 |
| Depreciation | 0.93 | 1.19 | 0.58 | 0.57 | 0.60 | 0.57 | 0.56 | 0.49 | 0.58 | 0.52 | 0.60 | 0.61 | 0.63 |
| Profit before tax | 2.09 | 1.96 | 2.42 | 2.22 | 2.14 | 1.73 | 2.02 | 0.83 | 3.32 | 9.65 | 5.85 | 9.14 | 5.95 |
| Tax % | 27.75% | 27.04% | 36.78% | 36.04% | 34.11% | 34.68% | 27.72% | 25.30% | 21.39% | 13.78% | 14.02% | 15.43% | |
| Net Profit | 1.52 | 1.43 | 1.53 | 1.42 | 1.41 | 1.12 | 1.47 | 0.61 | 2.61 | 8.32 | 5.03 | 7.74 | 4.90 |
| EPS in Rs | 4.54 | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 23.10 | 14.63 |
| Dividend Payout % | 77.14% | 81.99% | 76.63% | 82.57% | 83.16% | 104.69% | 0.00% | 0.00% | 44.92% | 14.09% | 23.31% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -5.92% | 6.99% | -7.19% | -0.70% | -20.57% | 31.25% | -58.50% | 327.87% | 218.77% | -39.54% | 53.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | 12.91% | -14.18% | 6.49% | -19.86% | 51.82% | -89.75% | 386.37% | -109.09% | -258.32% | 93.42% |
NG Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 36% |
| 3 Years: | 69% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 27% |
| 3 Years: | 22% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:46 pm
Balance Sheet
Last Updated: December 4, 2025, 3:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 |
| Reserves | 10.97 | 10.99 | 11.11 | 8.97 | 8.50 | 7.62 | 5.99 | 11.66 | 20.56 | 24.85 | 32.79 | 35.17 | 35.81 |
| Borrowings | 1.85 | 1.07 | 1.17 | 1.91 | 1.48 | 1.25 | 3.02 | 0.27 | 0.51 | 0.59 | 1.18 | 1.78 | 1.06 |
| Other Liabilities | 1.63 | 1.56 | 1.58 | 0.15 | 0.26 | 1.10 | 1.55 | 1.78 | 2.74 | 1.93 | 2.60 | 1.32 | 2.80 |
| Total Liabilities | 17.80 | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 43.02 |
| Fixed Assets | 6.00 | 5.09 | 4.87 | 4.90 | 4.96 | 5.16 | 5.26 | 5.35 | 5.56 | 5.19 | 5.62 | 5.64 | 5.38 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.53 | 8.40 | 8.89 | 4.30 | 4.24 | 3.37 | 3.84 | 8.16 | 16.15 | 22.27 | 28.95 | 31.94 | 33.32 |
| Other Assets | 4.27 | 3.48 | 3.45 | 5.18 | 4.39 | 4.79 | 4.81 | 3.55 | 5.45 | 3.26 | 5.35 | 4.04 | 4.32 |
| Total Assets | 17.80 | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 43.02 |
Below is a detailed analysis of the balance sheet data for NG Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.35 Cr..
- For Reserves, as of Sep 2025, the value is 35.81 Cr.. The value appears strong and on an upward trend. It has increased from 35.17 Cr. (Mar 2025) to 35.81 Cr., marking an increase of 0.64 Cr..
- For Borrowings, as of Sep 2025, the value is 1.06 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.78 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 0.72 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.32 Cr. (Mar 2025) to 2.80 Cr., marking an increase of 1.48 Cr..
- For Total Liabilities, as of Sep 2025, the value is 43.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.62 Cr. (Mar 2025) to 43.02 Cr., marking an increase of 1.40 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.38 Cr.. The value appears to be declining and may need further review. It has decreased from 5.64 Cr. (Mar 2025) to 5.38 Cr., marking a decrease of 0.26 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 33.32 Cr.. The value appears strong and on an upward trend. It has increased from 31.94 Cr. (Mar 2025) to 33.32 Cr., marking an increase of 1.38 Cr..
- For Other Assets, as of Sep 2025, the value is 4.32 Cr.. The value appears strong and on an upward trend. It has increased from 4.04 Cr. (Mar 2025) to 4.32 Cr., marking an increase of 0.28 Cr..
- For Total Assets, as of Sep 2025, the value is 43.02 Cr.. The value appears strong and on an upward trend. It has increased from 41.62 Cr. (Mar 2025) to 43.02 Cr., marking an increase of 1.40 Cr..
Notably, the Reserves (35.81 Cr.) exceed the Borrowings (1.06 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.89 | 1.59 | 1.96 | 0.97 | 1.58 | 1.57 | -0.23 | 0.99 | 1.85 | 1.30 | 0.83 | 0.01 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.59 | 4.67 | 6.47 | 8.87 | 9.67 | 10.74 | 9.27 | 10.14 | 15.46 | 1.37 | 3.24 | 9.48 |
| Inventory Days | 64.93 | 54.21 | 55.81 | 61.32 | 58.24 | 53.13 | 41.48 | 64.81 | 155.87 | 34.69 | 52.74 | 63.81 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 66.52 | 58.87 | 62.28 | 70.19 | 67.92 | 63.87 | 50.75 | 74.95 | 171.33 | 36.05 | 55.98 | 73.29 |
| Working Capital Days | -71.94 | -43.72 | -34.93 | -14.57 | -8.41 | -19.00 | -67.08 | -32.87 | 10.50 | -24.79 | -25.08 | -30.88 |
| ROCE % | 13.86% | 11.08% | 17.98% | 16.68% | 18.80% | 18.71% | 19.77% | 6.87% | 10.68% | 6.58% | 6.50% | 23.65% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.10 | 15.02 | 24.82 | 7.79 | 1.83 |
| Diluted EPS (Rs.) | 23.10 | 15.02 | 24.82 | 7.79 | 1.83 |
| Cash EPS (Rs.) | 24.93 | 16.80 | 26.39 | 9.51 | 3.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.96 | 107.85 | 84.17 | 71.36 | 44.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.96 | 107.85 | 84.17 | 71.36 | 44.79 |
| Dividend / Share (Rs.) | 3.50 | 3.50 | 3.50 | 3.50 | 0.00 |
| Revenue From Operations / Share (Rs.) | 49.39 | 50.39 | 55.82 | 54.98 | 35.47 |
| PBDIT / Share (Rs.) | 29.24 | 19.30 | 30.41 | 11.68 | 4.01 |
| PBIT / Share (Rs.) | 27.41 | 17.52 | 28.84 | 9.95 | 2.55 |
| PBT / Share (Rs.) | 27.28 | 17.47 | 28.80 | 9.90 | 2.48 |
| Net Profit / Share (Rs.) | 23.10 | 15.02 | 24.82 | 7.79 | 1.83 |
| PBDIT Margin (%) | 59.21 | 38.29 | 54.46 | 21.23 | 11.31 |
| PBIT Margin (%) | 55.51 | 34.77 | 51.66 | 18.10 | 7.18 |
| PBT Margin (%) | 55.24 | 34.67 | 51.58 | 18.01 | 7.00 |
| Net Profit Margin (%) | 46.77 | 29.81 | 44.46 | 14.16 | 5.16 |
| Return on Networth / Equity (%) | 20.09 | 13.93 | 29.48 | 10.91 | 4.09 |
| Return on Capital Employeed (%) | 23.44 | 15.37 | 33.49 | 13.08 | 5.68 |
| Return On Assets (%) | 18.59 | 12.60 | 27.07 | 9.60 | 3.64 |
| Total Debt / Equity (X) | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 0.40 | 0.47 | 0.64 | 0.83 | 0.77 |
| Current Ratio (X) | 1.65 | 2.88 | 1.60 | 3.11 | 1.32 |
| Quick Ratio (X) | 1.35 | 2.52 | 1.25 | 1.42 | 1.01 |
| Inventory Turnover Ratio (X) | 23.95 | 6.79 | 3.96 | 3.89 | 5.73 |
| Dividend Payout Ratio (NP) (%) | 15.15 | 23.29 | 14.10 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.04 | 20.83 | 13.26 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 84.85 | 76.71 | 85.90 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 85.96 | 79.17 | 86.74 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 223.85 | 403.73 | 768.27 | 250.81 | 65.49 |
| Interest Coverage Ratio (Post Tax) (X) | 177.82 | 315.31 | 628.15 | 168.26 | 30.89 |
| Enterprise Value (Cr.) | 54.07 | 51.23 | 25.60 | 19.88 | 11.95 |
| EV / Net Operating Revenue (X) | 3.27 | 3.03 | 1.37 | 1.08 | 1.01 |
| EV / EBITDA (X) | 5.52 | 7.92 | 2.51 | 5.08 | 8.88 |
| MarketCap / Net Operating Revenue (X) | 3.30 | 3.10 | 1.43 | 1.13 | 1.12 |
| Retention Ratios (%) | 84.84 | 76.70 | 85.89 | 0.00 | 0.00 |
| Price / BV (X) | 1.42 | 1.45 | 0.94 | 0.86 | 0.88 |
| Price / Net Operating Revenue (X) | 3.30 | 3.10 | 1.43 | 1.13 | 1.12 |
| EarningsYield | 0.14 | 0.09 | 0.31 | 0.12 | 0.04 |
After reviewing the key financial ratios for NG Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.93. This value is within the healthy range. It has increased from 16.80 (Mar 24) to 24.93, marking an increase of 8.13.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.96. It has increased from 107.85 (Mar 24) to 114.96, marking an increase of 7.11.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.96. It has increased from 107.85 (Mar 24) to 114.96, marking an increase of 7.11.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 3.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 49.39. It has decreased from 50.39 (Mar 24) to 49.39, marking a decrease of 1.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 29.24. This value is within the healthy range. It has increased from 19.30 (Mar 24) to 29.24, marking an increase of 9.94.
- For PBIT / Share (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 17.52 (Mar 24) to 27.41, marking an increase of 9.89.
- For PBT / Share (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has increased from 17.47 (Mar 24) to 27.28, marking an increase of 9.81.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
- For PBDIT Margin (%), as of Mar 25, the value is 59.21. This value is within the healthy range. It has increased from 38.29 (Mar 24) to 59.21, marking an increase of 20.92.
- For PBIT Margin (%), as of Mar 25, the value is 55.51. This value exceeds the healthy maximum of 20. It has increased from 34.77 (Mar 24) to 55.51, marking an increase of 20.74.
- For PBT Margin (%), as of Mar 25, the value is 55.24. This value is within the healthy range. It has increased from 34.67 (Mar 24) to 55.24, marking an increase of 20.57.
- For Net Profit Margin (%), as of Mar 25, the value is 46.77. This value exceeds the healthy maximum of 10. It has increased from 29.81 (Mar 24) to 46.77, marking an increase of 16.96.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 20.09, marking an increase of 6.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.44. This value is within the healthy range. It has increased from 15.37 (Mar 24) to 23.44, marking an increase of 8.07.
- For Return On Assets (%), as of Mar 25, the value is 18.59. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 18.59, marking an increase of 5.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.47 (Mar 24) to 0.40, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.65, marking a decrease of 1.23.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.52 (Mar 24) to 1.35, marking a decrease of 1.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 23.95. This value exceeds the healthy maximum of 8. It has increased from 6.79 (Mar 24) to 23.95, marking an increase of 17.16.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.15. This value is below the healthy minimum of 20. It has decreased from 23.29 (Mar 24) to 15.15, marking a decrease of 8.14.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.04. This value is below the healthy minimum of 20. It has decreased from 20.83 (Mar 24) to 14.04, marking a decrease of 6.79.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.85. This value exceeds the healthy maximum of 70. It has increased from 76.71 (Mar 24) to 84.85, marking an increase of 8.14.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.96. This value exceeds the healthy maximum of 70. It has increased from 79.17 (Mar 24) to 85.96, marking an increase of 6.79.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 223.85. This value is within the healthy range. It has decreased from 403.73 (Mar 24) to 223.85, marking a decrease of 179.88.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 177.82. This value is within the healthy range. It has decreased from 315.31 (Mar 24) to 177.82, marking a decrease of 137.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 54.07. It has increased from 51.23 (Mar 24) to 54.07, marking an increase of 2.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.27. This value exceeds the healthy maximum of 3. It has increased from 3.03 (Mar 24) to 3.27, marking an increase of 0.24.
- For EV / EBITDA (X), as of Mar 25, the value is 5.52. This value is within the healthy range. It has decreased from 7.92 (Mar 24) to 5.52, marking a decrease of 2.40.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Mar 24) to 3.30, marking an increase of 0.20.
- For Retention Ratios (%), as of Mar 25, the value is 84.84. This value exceeds the healthy maximum of 70. It has increased from 76.70 (Mar 24) to 84.84, marking an increase of 8.14.
- For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 1.42, marking a decrease of 0.03.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Mar 24) to 3.30, marking an increase of 0.20.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.14, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in NG Industries Ltd:
- Net Profit Margin: 46.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.44% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.09% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 177.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.48 (Industry average Stock P/E: 94.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 46.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | 1st Floor, Kolkata West Bengal 700029 | ngmail@ngil.co.in http://www.ngind.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh Goenka | Chairman & Wholetime Director |
| Mrs. Neha Goenka | Director |
| Mr. Pramod Kumar Dhelia | Director |
| Mr. Satya Prakash Tolasaria | Director |
FAQ
What is the intrinsic value of NG Industries Ltd?
NG Industries Ltd's intrinsic value (as of 18 December 2025) is 168.94 which is 36.24% higher the current market price of 124.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 41.6 Cr. market cap, FY2025-2026 high/low of 194/120, reserves of ₹35.81 Cr, and liabilities of 43.02 Cr.
What is the Market Cap of NG Industries Ltd?
The Market Cap of NG Industries Ltd is 41.6 Cr..
What is the current Stock Price of NG Industries Ltd as on 18 December 2025?
The current stock price of NG Industries Ltd as on 18 December 2025 is 124.
What is the High / Low of NG Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of NG Industries Ltd stocks is 194/120.
What is the Stock P/E of NG Industries Ltd?
The Stock P/E of NG Industries Ltd is 8.48.
What is the Book Value of NG Industries Ltd?
The Book Value of NG Industries Ltd is 117.
What is the Dividend Yield of NG Industries Ltd?
The Dividend Yield of NG Industries Ltd is 2.82 %.
What is the ROCE of NG Industries Ltd?
The ROCE of NG Industries Ltd is 23.6 %.
What is the ROE of NG Industries Ltd?
The ROE of NG Industries Ltd is 20.7 %.
What is the Face Value of NG Industries Ltd?
The Face Value of NG Industries Ltd is 10.0.